Whitehawk Therapeutics, Inc. (WHWK) — Defensive Interval Ratio
Whitehawk Therapeutics, Inc. (WHWK) has a Defensive Interval Ratio of 4620 days as of September 2025. Defensive assets of $124.67 Million (cash $-, short-term investments $124.67 Million, receivables $0.00) cover 4620 days of daily cash needs of $26.98K/day. Check how tangible is Whitehawk Therapeutics, Inc.'s equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Whitehawk Therapeutics, Inc. Defensive Interval Ratio (2019–2024)
This chart shows how Whitehawk Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 4620 days, meaning defensive assets of $124.67 Million can fund 4620 days of operations without new revenue. Also explore Whitehawk Therapeutics, Inc. (WHWK) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Whitehawk Therapeutics, Inc. (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for Whitehawk Therapeutics, Inc. from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Whitehawk Therapeutics, Inc..
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 523 days | $24.47 Million | $46.78K/day | $- | $18.57 Million | ▼ -188 days |
| 2023 | 711 days | $51.45 Million | $72.32K/day | $- | $45.96 Million | ▼ -1913 days |
| 2022 | 2624 days | $135.40 Million | $51.60K/day | $- | $133.54 Million | ▲ +2624 days |
| 2021 | 0 days | $0.00 | $41.84K/day | $- | $0.00 | ▼ -172 days |
| 2020 | 172 days | $14.15 Million | $82.35K/day | $- | $- | ▲ +168 days |
| 2019 | 4 days | $284.90K | $70.19K/day | $- | $- | — |